Yeo et al. report the use of SmartFlares (purchased from Merck Millipore) for the detection of mRNAs in cells and in skin tissues. 1 SmartFlares are the commercial version of the NanoFlares developed by the Mirkin group. Yeo et al. measure two quantitative parameters that, in light of other established facts about the cellular uptake of NanoFlares and mRNA biology, inform our understanding of the potential and limitations of NanoFlares.The first parameter is the maximum fold increase of signal upon activation. NanoFlare mRNA detection relies on an increase of fluorescence induced by the competitive displacement of a fluorescently-labelled detection probe by an mRNA target. The intact NanoFlares have a non-null fluorescence due to incomplete quenching of the probe. The ratio of the fluorescence signal after and before mRNA detection is therefore an important measure of performance. Yeo et al. measure this ratio by directly mixing NanoFlares with an excess of a "20-base-pair oligonucleotide perfectly complementary to the CTGF NanoFlare detection strand", (a) hereafter referred to as the target oligo, which mimics the defined fragment of CTGF mRNA. This resulted in a maximum fold increase upon activation of 5.5 (Fig. 1a) in qualitative agreement with other reports (Table 1). It is therefore surprising that in the same work yeo et al report fold differences which are larger than this ratio of 5.5 when comparing the CTGF NanoFlare signal between different cell lines (Fig. 1b).